FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Hesketh

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ethan Basch; Maurice Chesney; Rebecca A Clark-Snow; Petra Feyer; Anne Marie Flaherty; Barbara Freundlich; Paul J Hesketh; Mark G Kris; Gary H Lyman; Gary Morrow; Ann Alexis Prestrud; Kamakshi V Rao; Rowena N Schwartz; Mark R Somerfield
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
Steven M Grunberg; David Warr; Richard J Gralla; Bernardo L Rapoport; Paul J Hesketh; Karin Jordan; Birgitte T Espersen
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.
Mark G Kris; Maurizio Tonato; Emilio Bria; Enzo Ballatori; Birgitte Espersen; Jørn Herrstedt; Cynthia N Rittenberg; Lawrence H Einhorn; Steven M Grunberg; Mitsue Saito; Gary Morrow; Paul J Hesketh
Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Hesketh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ethan Basch; Maurice Chesney; Rebecca A Clark-Snow; Petra Feyer; Anne Marie Flaherty; Barbara Freundlich; Paul J Hesketh; Mark G Kris; Gary H Lyman; Gary Morrow; Ann Alexis Prestrud; Kamakshi V Rao; Rowena N Schwartz; Mark R Somerfield
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4189-98.
2011: Steven M Grunberg; David Warr; Richard J Gralla; Bernardo L Rapoport; Paul J Hesketh; Karin Jordan; Birgitte T Espersen
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19 Suppl 1():S43-7.
2011: Mark G Kris; Maurizio Tonato; Emilio Bria; Enzo Ballatori; Birgitte Espersen; Jørn Herrstedt; Cynthia N Rittenberg; Lawrence H Einhorn; Steven M Grunberg; Mitsue Saito; Gary Morrow; Paul J Hesketh
Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19 Suppl 1():S25-32.
2011: Elizabeth M Blanchard; James Moon; Paul J Hesketh; Karen Kelly; Antoinette J Wozniak; John Crowley; David R Gandara
Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(1):115-20.
2010: Elizabeth M Blanchard; Konstantinos Arnaoutakis; Paul J Hesketh
Lung cancer in octogenarians.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):909-16.
2007: Wallace Akerley; Jason McCoy; Paul J Hesketh; J Wendall Goodwin; James Bearden; James N Atkins; Kari Chansky; John J Crowley; David R Gandara
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(6):526-30.
2007: Paul J Hesketh; Rogerio Lilenbaum; Kari Chansky; Afshin Dowlati; Patricia Graham; Robert A Chapman; John J Crowley; David R Gandara
Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(6):494-8.
2007: Paul J Hesketh; Kari Chansky; Valerie Israel; Richard T Grapski; Tarek M Mekhail; C Harris Spiridonidis; Glenn M Mills; Karen Kelly; John J Crowley; David R Gandara
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5):440-4.
2006: Paul J Hesketh; Jason McCoy; Frank R Dunphy; James Bearden; Geoffrey R Weiss; Jeffrey K Giguere; James N Atkins; Shaker R Dakhil; Karen Kelly; John J Crowley; David R Gandara
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9):991-5.
2006: Paul J Hesketh; Kari Chansky; Derick H Lau; James Doroshow; Carol M Moinpour; Robert A Chapman; J Wendall Goodwin; Howard M Gross; John J Crowley; David R Gandara
Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(6):537-44.
2006: Mark G Kris; Paul J Hesketh; Mark R Somerfield; Petra Feyer; Rebecca A Clark-Snow; Jim M Koeller; Gary R Morrow; Lawrence W Chinnery; Maurice J Chesney; Richard J Gralla; Steven M Grunberg
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2932-47.
2006: Paul J Hesketh; Steven M Grunberg; Jørn Herrstedt; Ronald de Wit; Richard J Gralla; Alexandra D Carides; Arlene Taylor; Judith K Evans; kevin horgan
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(4):354-60.
2006: Fausto Roila; Paul J Hesketh; Jørn Herrstedt
Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(1):20-8.
2005: Jørn Herrstedt; Hyman Muss; David Warr; Paul J Hesketh; Peter D Eisenberg; Harry Raftopoulos; Steven M Grunberg; Munir Gabriel; Anthony Rodgers; Carolyn M Hustad; kevin horgan; Franck Skobieranda
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.
Cancer 2005;104(7):1548-55.
2005: David Warr; Steven M Grunberg; Richard J Gralla; Paul J Hesketh; Fausto Roila; Ronald de Wit; Alexandra D Carides; Arlene Taylor; Judith K Evans; kevin horgan
The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
European journal of cancer (Oxford, England : 1990) 2005;41(9):1278-85.
2005: David Warr; Paul J Hesketh; Richard J Gralla; Hyman Muss; Jørn Herrstedt; Peter D Eisenberg; Harry Raftopoulos; Steven M Grunberg; Munir Gabriel; Anthony Rodgers; Norman Bohidar; George Klinger; Carolyn M Hustad; kevin horgan; Franck Skobieranda
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2822-30.
2005: Thein H Oo; Paul J Hesketh
Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
Nature clinical practice. Oncology 2005;2(4):196-201.
2005: Steven M Grunberg; David Osoba; Paul J Hesketh; Richard J Gralla; Sussanne Borjeson; Bernardo L Rapoport; Andreas du Bois; Maurizio Tonato
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(2):80-4.
2005: Mark G Kris; Paul J Hesketh; Jørn Herrstedt; Cynthia N Rittenberg; Lawrence H Einhorn; Steven M Grunberg; Jim M Koeller; Ian Olver; Sussanne Borjeson; Enzo Ballatori
Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(2):85-96.
2005: Jørn Herrstedt; Jim M Koeller; Fausto Roila; Paul J Hesketh; David Warr; Cynthia N Rittenberg; Mario Dicato
Acute emesis: moderately emetogenic chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(2):97-103.
2004: Howard Safran; David A Iannitti; Ramesh K Ramanathan; Jonathan D Schwartz; Margaret Steinhoff; Chris Nauman; Paul J Hesketh; ritesh rathore; Robert Wolff; Umadevi Tantravahi; T Marilyn Hughes; Chris Maia; Terry Pasquariello; Lisa Goldstein; Thomas King; James Y Tsai; Teresa Kennedy
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.
Cancer investigation 2004;22(5):706-12.
2003: Thein H Oo; LEO S AISH; Douglas Schneider; Paul J Hesketh
Uncommon hematologic malignancies. Case 2. Calcification in untreated primary mediastinal large B-cell lymphoma with sclerosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4249-51.
2003: Paul J Hesketh; Steven M Grunberg; Richard J Gralla; David Warr; Fausto Roila; Ronald de Wit; Sant P Chawla; Alexandra D Carides; Juliana Ianus; Mary E Elmer; Judith K Evans; Klaus Beck; Scott A Reines; kevin horgan
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4112-9.
2003: Paul J Hesketh; Simon Van Belle; M Aapro; F David Tattersall; R J Naylor; Richard Hargreaves; Alexandra D Carides; Judith K Evans; kevin horgan
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1074-80.
2003: Sant P Chawla; Steven M Grunberg; Richard J Gralla; Paul J Hesketh; Cynthia N Rittenberg; Mary E Elmer; Carrie Schmidt; Arlene Taylor; Alexandra D Carides; Judith K Evans; kevin horgan
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Cancer 2003;97(9):2290-300.
2002: Thein H Oo; Leslie Martin; Paul J Hesketh
Adrenal hemorrhage secondary to metastasis from lung cancer.
Clinical lung cancer 2002;4(3):183-5.
2002: Jim M Koeller; Matti S Aapro; Richard J Gralla; Steven M Grunberg; Paul J Hesketh; Mark G Kris; Rebecca A Clark-Snow
Antiemetic guidelines: creating a more practical treatment approach.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2002;10(7):519-22.
2002: Paul J Hesketh; Christopher J Nauman; Ann M Hesketh; Janet LaPointe; Katrina Fogarty; Thein H Oo; Derick H Lau; Martin J Edelman; David R Gandara
Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer.
Clinical lung cancer 2002;4(1):47-51.
2001: Karen K Ballen; Ann M Hesketh; Christine Heyes; Pamela S Becker; Robert V B Emmons; K Fogarty; J LaPointe; Qin Liu; C C Hsieh; Paul J Hesketh
Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support.
Bone marrow transplantation 2001;28(11):1061-6.
2001: Howard Safran; H Gaissert; Paul Akerman; Paul J Hesketh; M H Chen; T Moore; J Koness; Stephen Graziano; Harold J Wanebo
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer.
Cancer investigation 2001;19(1):1-7.
2000: Paul J Hesketh; J R Crews; R Cohen; L M Blackburn; C J Friedman
Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy.
Cancer journal (Sudbury, Mass.) 2000;6(3):157-61.
2000: Howard Safran; Harold J Wanebo; Paul J Hesketh; Paul Akerman; D Ianitti; William G Cioffi; Thomas A DiPetrillo; B Wolf; J Koness; R McAnaw; T Moore; M H Chen; Kathy Radie-Keane
Paclitaxel and concurrent radiation for gastric cancer.
International journal of radiation oncology, biology, physics 2000;46(4):889-94.
2000: Paul J Hesketh
Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting.
Cancer investigation 2000;18(2):163-73.
2000: Paul J Hesketh; A Roman; Ann M Hesketh; E A Perez; Martin J Edelman; David R Gandara
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2000;8(1):46-8.
1999: Richard J Gralla; David Osoba; Mark G Kris; P Kirkbride; Paul J Hesketh; L W Chinnery; Rebecca A Clark-Snow; D P Gill; S Groshen; Steven M Grunberg; Jim M Koeller; Gary R Morrow; Edith A Perez; J H Silber; David G Pfister
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2971-94.
1999: Paul J Hesketh; John J Crowley; H A Burris; Stephen K Williamson; Stanley P Balcerzak; D Peereboom; J Wendall Goodwin; Howard M Gross; D F Moore; R B Livingston; David R Gandara
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
The cancer journal from Scientific American 1999;5(4):237-41.
1999: Howard Safran; Paul Akerman; William G Cioffi; H Gaissert; P Joseph; T King; Paul J Hesketh; Harold J Wanebo
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
Seminars in radiation oncology 1999;9(2 Suppl 1):53-7.
1999: Rudolph M Navari; Rick R Reinhardt; Richard J Gralla; Mark G Kris; Paul J Hesketh; A Khojasteh; H Kindler; Tobias Grote; Kelly Pendergrass; Steven M Grunberg; Alexandra D Carides; Barry J Gertz
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
The New England journal of medicine 1999;340(3):190-5.
1999: Paul J Hesketh; Richard J Gralla; R T Webb; W Ueno; S DelPrete; M E Bachinsky; N L Dirlam; C B Stack; Sandra Silberman
Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):338-43.
1999: Paul J Hesketh
Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
The oncologist 1999;4(3):191-6.
1998: J B Whitmore; Mark G Kris; Paul J Hesketh; Tobias Grote; D M DuBois; MB Cramer; WF Hahne
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(5):473-8.
1998: Paul J Hesketh; Richard J Gralla; Andreas du Bois; Maurizio Tonato
Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(3):221-7.
1998: Richard J Gralla; Rudolph M Navari; Paul J Hesketh; W Popovic; J Strupp; J Noy; L Einhorn; David S Ettinger; W Bushnell; C Friedman
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1568-73.
1998: Edith A Perez; Paul J Hesketh; J Sandbach; J Reeves; S Chawla; M Markman; J Hainsworth; W Bushnell; C Friedman
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):754-60.
1997: Enzo Ballatori; Fausto Roila; Verena de Angelis; G Ciccarese; MA Palladino; Maurizio Tonato; Albano Del Favero; Jørn Herrstedt; Mario Dicato; Andreas du Bois; Paul J Hesketh; Mark G Kris; Richard J Gralla
Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions. Multinational Association of Supportive Care in Cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(4):269-73.
1997: Paul J Hesketh; David R Gandara; Ann M Hesketh; Martin J Edelman; L M Webber; M McManus; J D Hainsworth
Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
The cancer journal from Scientific American 1997;3(3):180-3.
1997: Edward B Rubenstein; Richard J Gralla; J D Hainsworth; Paul J Hesketh; Tobias Grote; M R Modiano; A Khojasteh; L A Kalman; C R Benedict; WF Hahne
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group.
Cancer 1997;79(6):1216-24.
1997: Howard Safran; T P King; Hak Choy; Paul J Hesketh; B Wolf; E Altenhein; William Sikov; Alan G Rosmarin; Wallace Akerley; Kathy Radie-Keane; G Cicchetti; F Lopez; Kirby I Bland; Harold J Wanebo
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):901-7.
1997: Tobias Grote; L F Pineda; R A Figlin; Kelly Pendergrass; Paul J Hesketh; Beth Y Karlan; J A Reeves; L L Porter; C R Benedict; WF Hahne
Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.
The cancer journal from Scientific American 1997;3(1):45-51.
1997: Paul J Hesketh; Mark G Kris; Steven M Grunberg; T Beck; J D Hainsworth; G Harker; Matti S Aapro; David R Gandara; C M Lindley
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):103-9.
1996: Paul J Hesketh; Rudolph M Navari; Tobias Grote; Richard J Gralla; J Hainsworth; Mark G Kris; L Anthony; A Khojasteh; E Tapazoglou; C Benedict; W Hahne
Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(8):2242-9.
1996: H Burris; Paul J Hesketh; J Cohn; W Moriconi; T Ryan; C Friedman; D Fitts
Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
The cancer journal from Scientific American 1996;2(2):85-90.
1996: Paul J Hesketh; David R Gandara; A M Hesketh; A Facada; E A Perez; L M Webber; L A Martin; M B Cramer; W F Hahne
Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1996;4(2):141-6.
1995: Paul J Hesketh; T Beck; M Uhlenhopp; Mark G Kris; J D Hainsworth; W G Harker; J R Cohen; E Lester; J F Kessler; D Griffen
Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):2117-22.
1995: Rudolph M Navari; David R Gandara; Paul J Hesketh; S Hall; J Mailliard; H Ritter; C Friedman; D Fitts
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1242-8.
1994: S Tansan; Salih Emri; T Selçuk; Y Koç; Paul J Hesketh; T Heeren; R P McCaffrey; Y I Bariş
Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon.
Oncology 1994;51(4):348-51.
1994: Paul J Hesketh; W H Harvey; W G Harker; T M Beck; T Ryan; L J Bricker; J A Kish; W K Murphy; J D Hainsworth; B Haley
A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):596-600.
1993: Paul J Hesketh; P Caguioa; H Koh; H Dewey; A Facada; R McCaffrey; K Parker; P Nylen; T Woodworth
Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1682-90.
1993: Paul J Hesketh; S Tansan; P B Caguioa; A Hesketh; R Blanchard; N DiMartino; D Carney
Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C.
Cancer 1993;71(3):717-20.
1993: David R Gandara; W H Harvey; G G Monaghan; E A Perez; Paul J Hesketh
Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo.
European journal of cancer (Oxford, England : 1990) 1993;29A Suppl 1():S35-8.
1992: J D Hainsworth; Paul J Hesketh
Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results.
Seminars in oncology 1992;19(6 Suppl 15):14-9.
1992: T M Beck; Paul J Hesketh; S Madajewicz; Rudolph M Navari; Kelly Pendergrass; E P Lester; J A Kish; W K Murphy; J D Hainsworth; David R Gandara
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1969-75.
1992: David R Gandara; W H Harvey; G G Monaghan; E A Perez; C Stokes; J C Bryson; A L Finn; Paul J Hesketh
The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.
Seminars in oncology 1992;19(4 Suppl 10):67-71.
1992: Paul J Hesketh
Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis.
Seminars in oncology 1992;19(4 Suppl 10):33-40.
1991: Paul J Hesketh; David R Gandara
Serotonin antagonists: a new class of antiemetic agents.
Journal of the National Cancer Institute 1991;83(9):613-20.
1991: J Hainsworth; W Harvey; Kelly Pendergrass; B Kasimis; D Oblon; G Monaghan; David R Gandara; Paul J Hesketh; A Khojasteh; G Harker
A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):721-8.
1991: E A Perez; Paul J Hesketh; David R Gandara
Serotonin antagonists in the management of cisplatin-induced emesis.
Seminars in oncology 1991;18(1 Suppl 3):73-80.
1989: Paul J Hesketh; Clapp Richard; W G Doos; S J Spechler
The increasing frequency of adenocarcinoma of the esophagus.
Cancer 1989;64(2):526-30.
1989: Paul J Hesketh; W K Murphy; E P Lester; David R Gandara; A Khojasteh; E Tapazoglou; G P Sartiano; D R White; K Werner; J M Chubb
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(6):700-5.
1988: Paul J Hesketh; T P Cooley; H E Finkel; J Wright; A M Hesketh
Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C.
Cancer 1988;62(8):1466-70.